Skip to content
CA.gov logo in white
  • Grants Management System
  • CIRM Hub Portal
  • Contact
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Strategic Goals
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Strategic Goals
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops

hESC-derived NPCs Programmed with MEF2C for Cell Transplantation in Parkinson’s Disease

  • Post author:
  • Post published:March 15, 2026
  • Post category:

We proposes to use human embryonic stem cells (hESCs) differentiated into neural progenitor/stem cells (NPCs), but modified by transiently programming the cells with the transcription factor MEF2C to drive them…

Continue ReadinghESC-derived NPCs Programmed with MEF2C for Cell Transplantation in Parkinson’s Disease

Increasing the endogenous mesenchymal stem cells to the bone surface to treat osteoporosis

  • Post author:
  • Post published:March 15, 2026
  • Post category:

Although most individuals are aware that osteoporosis is disease of increased bone fragility that results from estrogen deficiency and aging, most are unaware of the high risk and cost of…

Continue ReadingIncreasing the endogenous mesenchymal stem cells to the bone surface to treat osteoporosis

A CIRM Disease Team to Develop Allopregnanolone for Prevention and Treatment of Alzheimer’s Disease

  • Post author:
  • Post published:March 15, 2026
  • Post category:

Alzheimer’s disease (AD) is now a nation-wide epidemic and California is at the epicenter of the epidemic. One-tenth of all people in the United States diagnosed with AD live in…

Continue ReadingA CIRM Disease Team to Develop Allopregnanolone for Prevention and Treatment of Alzheimer’s Disease

Clinical Development of an osteoinductive therapy to prevent osteoporosis-related fractures

  • Post author:
  • Post published:March 15, 2026
  • Post category:

There are over 1.5 million osteoporotic fractures annually in the USA alone, at a cost of approximately $15 billion each year. The majority of these fractures occur in the spine,…

Continue ReadingClinical Development of an osteoinductive therapy to prevent osteoporosis-related fractures

Human Embryonic Stem Cell-Derived Cardiomyocytes for Patients with End Stage Heart Failure

  • Post author:
  • Post published:March 15, 2026
  • Post category:

Patients with end-stage heart failure (ESHF) have a 2-year survival rate of 50% with conventional medical therapy. This dismal survival rate is actually significantly worse than patients with AIDS, liver…

Continue ReadingHuman Embryonic Stem Cell-Derived Cardiomyocytes for Patients with End Stage Heart Failure

Airways for Children

  • Post author:
  • Post published:March 15, 2026
  • Post category:

The primary goal is to bring a safe and effective therapy to children with severe large airway disease. Our intent is to implement all of the necessary steps for a…

Continue ReadingAirways for Children

Genetic Re-programming of Stem Cells to Fight Cancer

  • Post author:
  • Post published:March 15, 2026
  • Post category:

Science has made great progress in the treatment of certain cancers with targeted and combination therapies, yet prolonged remissions or cures are rare because most cancer therapies only inhibit cell…

Continue ReadingGenetic Re-programming of Stem Cells to Fight Cancer

GENE-MODIFIED HEMATOPOIETIC STEM/PROGENITOR CELL BASED THERAPY FOR HIV DISEASE

  • Post author:
  • Post published:March 15, 2026
  • Post category:

Continue ReadingGENE-MODIFIED HEMATOPOIETIC STEM/PROGENITOR CELL BASED THERAPY FOR HIV DISEASE

Embryonic-Derived Neural Stem Cells for Treatment of Motor Sequelae following Sub-cortical Stroke

  • Post author:
  • Post published:March 15, 2026
  • Post category:

A stroke kills brain cells by interrupting blood flow. The most common “ischemic stroke” is due to blockage in blood flow from a clot or narrowing in an artery. Brain…

Continue ReadingEmbryonic-Derived Neural Stem Cells for Treatment of Motor Sequelae following Sub-cortical Stroke

Stem Cell-Derived Astrocyte Precursor Transplants in Amyotrophic Lateral Sclerosis

  • Post author:
  • Post published:March 15, 2026
  • Post category:

Amyotrophic lateral sclerosis (ALS), a lethal disease lacking effective treatments, is characterized by the loss of upper and lower motor neurons. 5-10% of ALS is familial, but the majority of…

Continue ReadingStem Cell-Derived Astrocyte Precursor Transplants in Amyotrophic Lateral Sclerosis
  • Go to the previous page
  • 1
  • …
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • Go to the next page
  • Careers
  • Administrative & Financials
  • Accessibility

Subscribe to Receive CIRM News

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox. 

Sign Up
Facebook-f X-twitter Instagram Linkedin Youtube
  • Privacy Policy
  • ©2025 California Institute for Regenerative Medicine
  • Media Guidelines
  • Contact Us